OS Therapies Incorporated (OSTX)

NYSEAMERICAN: OSTX · Real-Time Price · USD

1.610

+0.010 (0.63%)

At close: Oct 1, 2026, 4:00 PM EDT

1.610

0.00 (0.00%)

After-hours: Oct 1, 2026, 6:30 PM EDT

OS Therapies Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	0.21	0.27	5.53	0.04	0.17	0.08
Cash & Short-Term Investments	0.21	0.27	5.53	0.04	0.17	0.08
Cash Growth	-92.68%	-95.12%	14095.08%	-77.27%	112.26%	-93.45%
Receivables	3.1	-	-	-	0	0.23
Prepaid Expenses	0.34	0.06	-	-	-	-
Other Current Assets	-	-	-	0.75	0.32	0
Total Current Assets	3.64	0.33	5.53	0.79	0.5	0.31
Property, Plant & Equipment	0	0	0.01	0.01	0.01	0.01
Other Intangible Assets	6.26	6.5	-	-	-	-
Total Assets	9.9	6.84	5.54	0.8	0.51	0.33

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Accounts Payable	20.25	9.94	1.66	2.72	1.23	0.86
Accrued Expenses	0.02	1.45	0.62	2.33	1.66	0.93
Short-Term Debt	-	-	-	2.48	-	-
Current Portion of Long-Term Debt	-	-	-	12.13	-	-
Other Current Liabilities	0.38	0.38	2.35	5.05	3.26	1.71
Total Current Liabilities	20.64	11.76	4.63	24.71	6.15	3.5
Long-Term Debt	-	-	-	-	10.35	7.07
Long-Term Unearned Revenue	0.1	0.1	0.1	0.1	0.1	0.1
Other Long-Term Liabilities	-	-	-	-	1.47	1.11
Total Liabilities	20.74	11.86	4.73	24.81	18.07	11.78

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Common Stock	0.05	0.04	0.02	0.01	0.01	0.01
Additional Paid-In Capital	74.26	61.05	35.14	5.5	4.03	3.76
Retained Earnings	-86.22	-67.19	-38.43	-29.52	-21.6	-15.22
Total Common Equity	-11.91	-6.1	-3.27	-24.02	-17.56	-11.45
Shareholders' Equity	-10.84	-5.02	0.81	-24.02	-17.56	-11.45
Total Liabilities & Equity	9.9	6.84	5.54	0.8	0.51	0.33

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Total Debt	-	-	-	14.61	10.35	7.07
Net Cash (Debt)	0.21	0.27	5.53	-14.57	-10.18	-6.99
Net Cash Growth	-92.68%	-95.12%	-	-	-	-
Net Cash Per Share	0.01	0.01	0.80	-2.68	-1.02	-0.70
Filing Date Shares Outstanding	46.13	39.53	21.66	11.98	10.72	10.72
Total Common Shares Outstanding	45.28	37.11	20.87	10.68	9.98	9.98
Working Capital	-17	-11.43	0.91	-23.92	-5.65	-3.18
Book Value Per Share	-0.26	-0.16	-0.16	-2.25	-1.76	-1.15
Tangible Book Value	-18.17	-12.6	-3.27	-24.02	-17.56	-11.45
Tangible Book Value Per Share	-0.40	-0.34	-0.16	-2.25	-1.76	-1.15

SEC Filings: 10-K · 10-Q